Quantification of Plasma Cell-Free Circulating DNA at Different Stages of Colorectal Cancer

References

• Akbari A, Amanpour S, Muhammadnejad S, Ghahremani MH, Ghaffari SH, Dehpour AR, Mobini GR, Shidfar F, Abastabar M, Khoshzaban A, et al. Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adenocarcinoma. DARU J Pharm Sci. 2014;22(1):47. doi:10.1186/2008-2231-22-47. PMID: 24902843.
   PubMedGoogle Scholar
• Mirzaei A, Tavoosidana G, Modarressi MH, Rad AA, Fazeli MS, Shirkoohi R, Tavakoli-Yaraki M, Madjd Z. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients. Tumor 2015;36(6):4801–4810. doi:10.1007/s13277-015-3132-9. PMID: 25631749.
   PubMedGoogle Scholar
• Akbari A, Agah S, Heidari M, Mobini GR, Faghihloo E, Sarveazad A, Mirzaei A. Homeodomain Protein Transforming Growth Factor Beta-Induced Factor 2 Like, X-Linked Function in Colon Adenocarcinoma Cells. Asian Pac J Cancer Prev. 2017; 18(8):2101–2108.
   Google Scholar
• Akbari A, Mobini GR, Maghsoudi R, Akhtari J, Faghihloo E, Farahnejad Z. Modulation of transforming growth factor-β signaling transducers in colon adenocarcinoma cells induced by staphylococcal enterotoxin B. Mol Med Rep 2016;13(1):909–914. doi:10.3892/mmr.2015.4596. PMID: 26647993.
   PubMed Web of Science ®Google Scholar
• Mobini GR, Ghahremani MH, Amanpour S, Dehpour AR, Akbari A, Hoseiniharouni SM, Muhammadnejad S, Sheikhzade M, Abedkhojasteh H, Mohebi M, et al. Transforming growth factor beta-induced factor 2-linked X (TGIF2LX) regulates two morphogenesis genes, Nir1 and Nir2 in human colorectal. Acta Medica Iranica 2016;54(5):302–307. PMID: 27309477.
   PubMedGoogle Scholar
• Akbari A, Ghahremani MH, Mobini GR, Abastabar M, Akhtari J, Bolhassani M, Heidari M. Down-regulation of miR-135b in colon adenocarcinoma induced by a TGF-β receptor I kinase inhibitor (SD-208). Iran J Basic Med Sci 2015;18(9):856. PMID: 26523217.
   PubMed Web of Science ®Google Scholar
• Mirzaei A, Madjd Z, Kadijani AA, Tavakoli-Yaraki M, Modarresi MH, Verdi J, Akbari A, Tavoosidana G. Evaluation of circulating cellular DCLK1 protein, as the most promising colorectal cancer stem cell marker, using immunoassay based methods. Cancer Biomark 2016;17(3):301–311. doi:10.3233/CBM-160642. PMID: 27802206.
   PubMed Web of Science ®Google Scholar
• Utting M, Werner W, Dahse R, Schubert J, Junker K. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients. Clin Cancer Res 2002;8(1):35–40. PMID: 11801538.
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer—A survey. Biochim Biophys Acta 2007;1775(1):181–232. doi:10.1016/j.bbcan.2006.10.001..
   PubMed Web of Science ®Google Scholar
• Thierry AR, El Messaoudi S, Gahan, P.B, Anker P, Stroun M. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 2016;35:347. doi:10.1007/s10555-016-9629-x. PMID: 27392603.
   PubMed Web of Science ®Google Scholar
• Wan JC, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: Towards implementation of circulating tumour DNA. Nat Rev Cancer 2017;17:223–238. doi:10.1038/nrc.2017.7. PMID: 28233803.
   PubMed Web of Science ®Google Scholar
• Stroun M, Lyautey J, Lederrey C, Olson-Sand A, Anker P. About the possible origin and mechanism of circulating DNA: Apoptosis and active DNA release. Clinica Chimica Acta 2001;313(1):139–142. doi:10.1016/S0009-8981(01)00665-9..
   PubMed Web of Science ®Google Scholar
• van der Vaart M, Pretorius PJ. The origin of circulating free DNA. Clin Chem 2007;53(12):2215–2215. doi:10.1373/clinchem.2007.092734. PMID: 18267930.
   PubMed Web of Science ®Google Scholar
• Taback B, O'Day SJ, Boasberg PD, Shu S, Fournier P, Elashoff R, Wang HJ, Hoon DS. Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma. J Natl Cancer Inst 2004;96(2):152–156. doi:10.1093/jnci/djh011. PMID: 14734706.
   PubMedGoogle Scholar
• Takagi R, Nakamoto D, Mizoe JE, Tsujii H. LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck. Int J Clin Oncol 2007;12(3):199–204. doi:10.1007/s10147-006-0650-x. PMID: 17566843.
   PubMed Web of Science ®Google Scholar
• Rawnaq T, Schwarzenbach H, Schurr PG, Freise K, Brandl S, Izbicki JR, Kaifi JT. Monitoring of loss of heterozygosity in serum microsatellite DNA among patients with gastrointestinal stromal tumors indicates tumor recurrence. J Surg Res 2011;169(1):31–35. doi:10.1016/j.jss.2009.12.032. PMID: 20417938.
   PubMed Web of Science ®Google Scholar
• Kakimoto Y, Yamamoto N, Shibahara T. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma. Oncol Rep 2008;20(5):1195–200. PMID: 18949421.
   PubMed Web of Science ®Google Scholar
• Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004;429(6990):457–463. doi:10.1038/nature02625. PMID: 15164071.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Müller V, Stahmann N, Pantel K. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer. Ann N Y Acad Sci 2004;1022(1):25–32. doi:10.1196/annals.1318.005. PMID: 15251935.
   PubMedGoogle Scholar
• Ludovini V, Pistola L, Gregorc V, Floriani I, Rulli E, Piattoni S, Di Carlo L, Semeraro A, Darwish S, Tofanetti FR, et al. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: A study of the perugia multidisciplinary team for thoracic oncology. J Thorac Oncol 2008;3(4):365–373. doi:10.1097/JTO.0b013e318168c7d0. PMID: 18379354.
   PubMed Web of Science ®Google Scholar
• Akbari A, Farahnejad Z, Akhtari J, Abastabar M, Mobini G R, et al. Staphylococcus aureus Enterotoxin B Down-Regulates the Expression of Transforming Growth Factor-Beta (TGF-β) Signaling Transducers in Human Glioblastoma, Jundishapur J Microbiol. 2016;9(5):e60055. doi: 10.5812/jjm.27297.
   Web of Science ®Google Scholar
• Faghihloo E, Akbari A, Adjaminezhad-Fard F, Mokhtari-Azad T. Transcriptional regulation of E-cadherin and oncoprotein E7 by valproic acid in HPV positive cell lines. Iran J Basic Med Sci 2016;19(6):601. PMID: 27482340.
   PubMed Web of Science ®Google Scholar
• Szpechcinski A, Struniawska R, Zaleska J, Chabowski M, Orlowski T, Roszkowski K, Chorostowska-Wynimko J. Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients. J Physiol Pharmacol 2008;59(Suppl 6):675–81. PMID: 19218694.
   PubMed Web of Science ®Google Scholar
• Jung M, Klotzek S, Lewandowski M, Fleischhacker M, Jung K. Changes in concentration of DNA in serum and plasma during storage of blood samples. Clin Chem 2003;49(6):1028–1029. doi:10.1373/49.6.1028. PMID: 12766024.
   PubMed Web of Science ®Google Scholar
• Taback, B, SJ O'day, and DS Hoon. Quantification of circulating DNA in the plasma and serum of cancer patients. Ann N Y Acad Sci 2004;1022(1):17–24. doi:10.1196/annals.1318.004. PMID: 15251934.
   PubMedGoogle Scholar
• Park J-L, Kim HJ, Choi BY, Lee HC, Jang HR, Song KS, Noh SM, Kim SY, Han DS, Kim YS. Quantitative analysis of cell-free DNA in the plasma of gastric cancer patients. Oncol Lett 2012;3(4):921–926. PMID: 22741019.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Stoehlmacher J, Pantel K, Goekkurt E. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer. Ann N Y Acad Sci 2008;1137(1):190–196. doi:10.1196/annals.1448.025. PMID: 18837946.
   PubMedGoogle Scholar
• Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, et al. Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma. Anticancer Res 2006;26(6C):4713–4719. PMID: 17214331.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Pan SY, Xia WY, Chen D, Wang H, Zhang LX, Xu J, Peng Y, Qiu HR, Miao KR, et al. Dynamic monitoring of plasma circulating DNA in patients with acute myeloid leukemia and its clinical significance. J Exp Hematol 2012;20(1):53–56.
   Google Scholar
• Yoon K-A, Park S, Lee SH, Kim JH, Lee JS. Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls. J Mol Diagn 2009;11(3):182–185. doi:10.2353/jmoldx.2009.080098. PMID: 19324991.
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Bryzgunova OE, Rykova EY, Permyakova VI, Vlassov VV, Laktionov PP. Circulating nucleic acids in blood of healthy male and female donors. Clin Chem 2005;51(7):4801317–1319. doi:10.1373/clinchem.2004.045062. PMID: 15976134.
   PubMed Web of Science ®Google Scholar
• Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003;21(21):3902–3908. doi:10.1200/JCO.2003.02.006. PMID: 14507943.
   PubMed Web of Science ®Google Scholar
• Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, et al. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009;64(1):92–97. doi:10.1016/j.lungcan.2008.07.012. PMID: 18804892.
   PubMed Web of Science ®Google Scholar
• Frattini M, Gallino G, Signoroni S, Balestra D, Battaglia L, Sozzi G, Leo E, Pilotti S, Pierotti MA. Quantitative analysis of plasma DNA in colorectal cancer patients. Ann N Y Acad Sci 2006;1075(1):185–190. doi:10.1196/annals.1368.025. PMID: 17108210.
   PubMedGoogle Scholar
• Holdenrieder S, Von Pawel J, Nagel D, Stieber P. Long-term stability of circulating nucleosomes in serum. Anticancer Res 2010;30(5):1613–1615. PMID: 20592350.
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Cherepanova AV, Kolesnikova EV, Rykova EY, Pyshnyi DV, Vlassov VV, Laktionov PP. Circulating DNA and DNase activity in human blood. Ann N Y Acad Sci 2006;1075(1):191–196. doi:10.1196/annals.1368.026. PMID: 17108211.
   PubMedGoogle Scholar
• Choi JJ, Reich CF, Pisetsky DS. The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells. Immunology 2005;115(1):55–62. doi:10.1111/j.1365-2567.2005.02130.x. PMID: 15819697.
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Litviakov NV, Bryzgunova OE, Dobrodeev AY, Rykova EY, Tuzikov SA, Zav'ialov AA, Vlassov VV, Cherdyntseva NV, Laktionov PP. Cell-surface-bound circulating DNA as a prognostic factor in lung cancer. Ann N Y Acad Sci 2008;1137(1):214–217. doi:10.1196/annals.1448.042. PMID: 18837949.
   PubMedGoogle Scholar
• Schmidt B, Weickmann S, Witt C, Fleischhacker M. Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann N Y Acad Sci 2008;1137(1):207–213. doi:10.1196/annals.1448.034. PMID: 18837948.
   PubMedGoogle Scholar
• Fleischhacker M, Schmidt B. Cell-free DNA resuscitated for tumor testing. Nature Med 2008;14(9):914–915. doi:10.1038/nm0908-914. PMID: 18776881.
   PubMed Web of Science ®Google Scholar
• Fadakar P, Akbari A, Ghassemi F, Mobini GR, Mohebi M, Bolhassani M, Abed Khojasteh H, Heidari M. Evaluation of SD-208, a TGF-β-RI Kinase Inhibitor, as an Anticancer Agent in Retinoblastoma. Acta Med Iran. 2016;54(6):352–358.
   PubMedGoogle Scholar
• Kamat AA, Baldwin M, Urbauer D, Dang D, Han LY, Godwin A, Karlan BY, Simpson JL, Gershenson DM, Coleman RL, et al. Plasma cell-free DNA in ovarian cancer. Cancer 2010;116(8):1918–1925. doi:10.1002/cncr.24997. PMID: 20166213.
   PubMed Web of Science ®Google Scholar
• Kumar S, Guleria R, Singh V, Bharti AC, Mohan A, Das BC. Plasma DNA level in predicting therapeutic efficacy in advanced nonsmall cell lung cancer. Eur Respirator J 2010;36(4):885–892. doi:10.1183/09031936.00187909. PMID: 20185420.
   PubMed Web of Science ®Google Scholar
• Karimi A, Majidzadeh-A K, Madjd Z, Akbari A, Habibi L, Akrami SM. Effect of Copper Sulfate on Expression of Endogenous L1 Retrotransposons in HepG2 Cells (Hepatocellular Carcinoma). Biol Trace Elem Res. 2015;165:131–134.
   PubMed Web of Science ®Google Scholar
• Vlassov V, Laktionov P, Rykova E. Circulating nucleic acids as a potential source for cancer biomarkers. Curr Mol Med 2010;10(2):142–165. doi:10.2174/156652410790963295. PMID: 20196731.
   PubMed Web of Science ®Google Scholar
• Qin Z, Ljubimov VA, Zhou C, Tong Y, Liang J. Cell-free circulating tumor DNA in cancer. Chinese J Cancer 2016;35(1):36. doi:10.1186/s40880-016-0092-4. PMID: 27056366.
   PubMedGoogle Scholar
• Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol 2014;8(5):927–941. doi:10.1016/j.molonc.2014.02.005. PMID: 24698732.
   PubMed Web of Science ®Google Scholar
• Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, Galas DJ. Comparing the microRNA spectrum between serum and plasma. PloS One 2012;7(7):e41561. doi:10.1371/journal.pone.0041561. PMID: 22859996.
   PubMed Web of Science ®Google Scholar
• Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR. Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol 2014;8:927–941. doi:10.1016/j.molonc.2014.02.005. PMID: 24698732.
   PubMed Web of Science ®Google Scholar